Clinical Trial Update: First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 [Phase 1]

View source ↗

Summary

First-in-human study of ALS-002158 evaluated single-dose and food-effect in healthy volunteers and multiple-dose exposure in chronic hepatitis C genotype 1. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ALS-002158

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Hepatitis C, Chronic | Phase 1 | Status: TERMINATED